ARCHIMED
Magdalena Jurkiewicz has extensive experience in the healthcare and investment sectors, currently serving as a Board Member at Cellese Regenerative Therapeutics since April 2024. Since June 2021, Magdalena has held the dual role of Director and Associate Director at ARCHIMED, focusing on impacting healthcare. Prior to this, Magdalena dedicated fourteen years to Enterprise Investors, progressing from Research Assistant to Research Analyst, Business Analyst, and ultimately Investment Director. Magdalena holds a degree from SGH Warsaw School of Economics, completed in 2009.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.